Covina, June 28, 2023 (GLOBE NEWSWIRE) -- “According to the latest research study, the demand of “Induced Pluripotent Stem Cells Market accounted for US$ 1.8 billion in 2022 and is estimated to be US$ 3.5 billion by 2032 and is anticipated to register a CAGR of 6.8%.”
Induced Pluripotent Stem Cells (iPSC) are created by lentiviral or retroviral transduction. Beta islet cells for treating diabetes are example of Induced Pluripotent Stem Cells. Wide variety of uses in gene therapy and disease modelling have become major factor in market growth.
Presence of major key players and growing strategic partnerships and acquisitions has boost the demand for market growth. Growing prevalence of chronic diseases and improved healthcare infrastructure such as healthcare plans, presence of well advanced academic & research institutes has further facilitated the demand for Induced Pluripotent Stem Cells market growth.
What are the recent news in the Induced Pluripotent Stem Cells Market?
In June 2021, Catalent acquired RheinCell Therapeutics a German company and developer & manufacturer of GMP-grade human induced pluripotent stem cells for cell-based therapies. This acquisition will provide Catalent to strengthen its position in induced pluripotent stem cells market.
| Attribute | Details |
| Base year for estimation | 2022 |
| Forecast period | 2022 – 2032 |
| Accounted in 2022 | US$ 1.8 billion |
| Estimated to be in 2032 | US$ 3.5 billion |
| CAGR | 6.8% |
| Market representation | Revenue in USD Billion & CAGR from 2022 to 2032 |
| Market Segmentation | By Derived Cell Type - Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others. By Application - Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others By End-Users - Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others |
| Regional scope | North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Click Here to Get Free Sample Copy of this Report@
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5121
What is Prophecy’s Analyst View on Induced Pluripotent Stem Cells Market?
Various applications of iPSC in drug delivery research by creating human BBD (blood-brain barrier) micro physiological system which includes, endothelial cells, and human astrocytes derived from iPSCs where scientists can significantly accelerate the research of neuro-pharmaceutical drug delivery transport and screening which has provided lucrative opportunities in market growth. Growing research & development activities and government funding has further, expected to boost the demand for Induced Pluripotent Stem Cells market growth.
What are the key drivers of growth in the Induced Pluripotent Stem Cells Market?
The Induced Pluripotent Stem Cells Market is driven by several factors that contribute to its growth and advancement. Here are some key drivers:
- Disease modeling and drug discovery potential
- Advancements in reprogramming techniques
- Growing demand for personalized medicine
- Potential for regenerative medicine applications
- Collaborative research efforts
- Supportive regulatory environment
- Increasing investment and funding
What are the major challenges in the Induced Pluripotent Stem Cells Market?
The iPSCs market faces several significant challenges that impact its growth and development. These challenges include the need for improved reprogramming efficiency and reduced variability in iPSC generation. Ensuring safety and quality control is crucial, including minimizing genetic abnormalities and reducing the risk of tumorigenicity. Scalability and cost-effectiveness of iPSC production remain important considerations for widespread adoption.
Additionally, optimizing differentiation protocols to generate mature and functional cells, addressing intellectual property rights and patent issues, navigating complex regulatory landscapes, and addressing ethical considerations all pose challenges in the iPSCs market. Overcoming these challenges requires ongoing research, technological advancements, collaboration, and adherence to regulatory standards to advance the field and unlock the full potential of iPSCs.
Who are the key players or vendors in the Induced Pluripotent Stem Cells Market?
- Lonza
- Evotec SE
- Thermo Fisher Scientific Inc.
- Axol Bioscience Ltd.
- Merck KGaA
- Fate Therapeutics
- Hitachi Ltd.
- Cynata Therapeutics Limited
- Applied StemCells Inc.
- REPROCELLS Inc.
Download PDF Brochure:
https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/5121
What are the emerging trends and technologies in Induced Pluripotent Stem Cells Market?
Emerging trends and technologies in the Induced Pluripotent Stem Cells (iPSCs) market include advanced differentiation techniques for efficient and scalable production of mature cell types, gene editing technologies like CRISPR-Cas9 for precise genetic modifications, and the integration of artificial intelligence and machine learning for data analysis and prediction. Other trends include the use of organ-on-a-chip systems to mimic organ functionality, bioprinting and tissue engineering for creating complex tissue structures, and the application of automation and robotics to streamline iPSC generation and maintenance. These advancements have the potential to drive innovation, accelerate therapeutic discoveries, and expand the applications of iPSCs in regenerative medicine and drug development.
What are Key Benefits of Induced Pluripotent Stem Cells Market?
- Disease modeling and understanding
- Drug discovery and development
- Personalized medicine applications
- Potential for regenerative medicine
- Ethical advantages compared to embryonic stem cells
- Reduced risk of immune rejection in transplantation
- Advancement of disease treatment and therapies
- Commercial opportunities for research and industry growth
- Precision medicine advancements based on individual genetic profiles
Key Questions Answered in Report:
- What is the current market size and projected growth rate of the Induced Pluripotent Stem Cells Market?
- What are the key factors driving the growth of the Induced Pluripotent Stem Cells Market?
- What are the major challenges and barriers in the Induced Pluripotent Stem Cells Market?
- What are the potential therapeutic applications of Induced Pluripotent Stem Cells Market and which diseases can be targeted?
- What are the emerging trends and technologies in Induced Pluripotent Stem Cells Market research and development?
- Who are the leading companies and academic institutions involved in the Induced Pluripotent Stem Cells Market?
Please Find Below Some Related Reports:
Stem Cell Assay Market - By Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays), By Kit (Adult Stem Cells Kit and Human Embryonic Stem Cells Kits), By Detection (Instruments and Detection Kits), By Instrument (Flow Cytometer, Micro Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter), By Application (Regenerative Medicine And Therapy Development, Drug Discovery & Development, and Clinical Research), By End User (Government Research Institutes, Private Research, and Industry Research), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030
Synthetic Stem Cells Market - By Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030
Human Embryonic Stem Cells (HESC) Market - By Type (Totipotent Stem Cells, Pluripotent Stem Cells, and Unipotent Stem Cells), By Application (Research and Clinical Trials), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029
Blog: www.prophecyjournals.com
Follow us on:
LinkedIn | Twitter | Facebook |YouTube
